Literature DB >> 1986916

Variable prevalence of lymphocytic thyroiditis among diabetes-prone sublines of BB/W or rats.

R Rajatanavin1, M C Appel, W Reinhardt, S Alex, Y N Yang, L E Braverman.   

Abstract

The BB/Wor rat develops spontaneous autoimmune insulin-dependent diabetes mellitus (DM) and lymphocytic thyroiditis (LT). Six different inbred sublines of this rat model have been selected for studying the pathogenesis of DM and, thereby, the prevalence of DM has been carefully monitored and found to be relatively constant. In contrast, we have observed a striking difference in the prevalence and intensity of LT in these six sublines, varying from 100% in NB subline rats to 4.9% in BE subline rats at 105-110 days of age. Excess iodide administration frequently increases the prevalence of LT but did not do so in the two sublines (BB and BE) with the lowest frequency of spontaneous LT. In view of this variable prevalence of LT in the different BB/Wor sublines, it is imperative that investigators studying the pathogenesis and modulation of LT in this rat model select those sublines which express a desired frequency of spontaneous LT.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1986916     DOI: 10.1210/endo-128-1-153

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Acute iodine ingestion increases intrathyroidal glutathione.

Authors:  E M Allen
Journal:  J Endocrinol Invest       Date:  1993-04       Impact factor: 4.256

2.  Thyroglobulin-reactive T lymphocytes in thyroiditis-prone BB/Wor rats.

Authors:  E M Allen; J N Thupari
Journal:  J Endocrinol Invest       Date:  1995-01       Impact factor: 4.256

3.  The effect of iodine on lipid peroxidation and ultrastructure in the thyroids of BB/Wor rats.

Authors:  E M Allen
Journal:  J Endocrinol Invest       Date:  1992 Jul-Aug       Impact factor: 4.256

4.  A major histocompatibility complex class II restriction for BioBreeding/Worcester diabetes-inducing T cells.

Authors:  K E Ellerman; A A Like
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.